Trial intelligence / Profile preview

Paracetamol for Brain Temperature in Acute Brain Injury

NCT03648021Phase 4Completed

Sponsor
Adolphe de Rothschild Foundation Hospital
Start
May 2018
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, triple-blind trial of acetaminophen in hyperthermia, sponsored by Adolphe de Rothschild Foundation Hospital. Primary endpoint: Mean brain temperature at 6 hours. Started May 2018; status: completed.

02

Drugs

acetaminophen
03

Conditions

hyperthermia

Beyond the preview

Go deeper on NCT03648021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03648021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call